GLB1 Antikörper (N-Term)
Kurzübersicht für GLB1 Antikörper (N-Term) (ABIN1888020)
Target
Alle GLB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- 17 amino acid peptide from near the amino terminus of E.coli beta-gal.
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
-
Handhabung
- Avoid freezing and thawing repeatly.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term use.Store at -20 °C for long term preservation.
-
-
- GLB1 (Galactosidase, beta 1 (GLB1))
-
Andere Bezeichnung
- beta-Galactosidase
-
Hintergrund
-
Beta-galactosidase (beta-gal), an inducible enzyme that catalyses the hydrolysis of lactose and other beta-galactosides into monosaccharides, is a product of the LacZ operon, and is a homo-tetrameric protein consisting of four identical subunits of approximately 114 kDa each.The enzyme is commonly used as a reporter gene in molecular biology to assess the efficiency of transfection.
Synonyms: beta-Galactosidase, beta-galactosidase, beta-gal -
NCBI Accession
- NP_752394
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-